IRIS Accounts Production v24.1.0.578 08741765 director 1.11.22 31.10.23 31.10.23 No description of principal activity 0 false true false false true true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh087417652022-10-31087417652023-10-31087417652022-11-012023-10-31087417652021-10-31087417652021-11-012022-10-31087417652022-10-3108741765ns15:EnglandWales2022-11-012023-10-3108741765ns14:PoundSterling2022-11-012023-10-3108741765ns10:Director12022-11-012023-10-3108741765ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3108741765ns10:SmallEntities2022-11-012023-10-3108741765ns10:AuditExemptWithAccountantsReport2022-11-012023-10-3108741765ns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3108741765ns10:SmallCompaniesRegimeForAccounts2022-11-012023-10-3108741765ns10:FullAccounts2022-11-012023-10-3108741765ns10:EntityHasNeverTraded2022-11-012023-10-3108741765ns10:RegisteredOffice2022-11-012023-10-3108741765ns5:CurrentFinancialInstruments2023-10-3108741765ns5:CurrentFinancialInstruments2022-10-3108741765ns5:ShareCapital2023-10-3108741765ns5:ShareCapital2022-10-3108741765ns5:RetainedEarningsAccumulatedLosses2023-10-3108741765ns5:RetainedEarningsAccumulatedLosses2022-10-3108741765ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3108741765ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-31
REGISTERED NUMBER: 08741765 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

Geobam Clinicals Limited

Geobam Clinicals Limited (Registered number: 08741765)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Report of the Accountants 4

Geobam Clinicals Limited

Company Information
for the Year Ended 31 October 2023







DIRECTOR: Ms A A Lawal





REGISTERED OFFICE: 6 Binbrook Walk
Corby
Northamptonshire
NN18 9HH





REGISTERED NUMBER: 08741765 (England and Wales)





ACCOUNTANTS: OAKS
Accountants
69 Bexley High Street
Bexley
Kent
DA5 1AA

Geobam Clinicals Limited (Registered number: 08741765)

Balance Sheet
31 October 2023

31.10.23 31.10.22
Notes £    £   
CURRENT ASSETS
Debtors 4 19,688 19,688
Cash at bank 1,211 1,211
20,899 20,899
CREDITORS
Amounts falling due within one year 5 13,520 13,520
NET CURRENT ASSETS 7,379 7,379
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,379

7,379

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 7,369 7,369
7,379 7,379

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 August 2024 and were signed by:





Ms A A Lawal - Director


Geobam Clinicals Limited (Registered number: 08741765)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. STATUTORY INFORMATION

Geobam Clinicals Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 1 ).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Other debtors 19,688 19,688

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.23 31.10.22
£    £   
Taxation and social security 1,721 1,721
Other creditors 11,799 11,799
13,520 13,520

Geobam Clinicals Limited

Report of the Accountants to the Director of
Geobam Clinicals Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 October 2023 set out on page nil and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






OAKS
Accountants
69 Bexley High Street
Bexley
Kent
DA5 1AA


5 August 2024